The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $45.81

Today's change+0.22 +0.48%
Updated September 3 4:02 PM EDT. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $45.81

Today's change+0.22 +0.48%
Updated September 3 4:02 PM EDT. Delayed by at least 15 minutes.

NU Skin Enterprises Inc up (U.S.)$0.22

NU Skin Enterprises Inc closed up Thursday by (U.S.)$0.22 or 0.48% to (U.S.)$45.81. Over the last five days, shares have gained 1.44% and 4.83% year to date. Shares have outperformed the S&P 500 by 11.68% during the last year.

Key company metrics

  • Open(U.S.) $45.58
  • Previous close(U.S.) $45.59
  • High(U.S.) $46.04
  • Low(U.S.) $45.25
  • Bid / Ask-- / --
  • YTD % change+4.83%
  • Volume439,225
  • Average volume (10-day)788,635
  • Average volume (1-month)1,177,091
  • Average volume (3-month)920,823
  • 52-week range(U.S.) $38.00 to (U.S.) $62.87
  • Beta1.38
  • Trailing P/E14.13×
  • P/E 1 year forward12.63×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield3.06%
  • Trailing EPS(U.S.) $3.24
Updated September 3 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.32%

Based on its net profit margin of 8.32%, NU Skin Enterprises Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.38%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue560543610639
Total other revenue--------
Total revenue560543610639
Gross profit450438503530
Total cost of revenue110105107109
Total operating expense488475518534
Selling / general / administrative378370412425
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income726991105
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax695675106
Income after tax45364768
Income tax, total24202938
Net income45364768
Total adjustments to net income--------
Net income before extra. items45364768
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items45364768
Inc. avail. to common incl. extra. items45364768
Diluted net income45364768
Dilution adjustment--------
Diluted weighted average shares60606161
Diluted EPS excluding extraordinary itemsvalue per share0.750.600.771.12
Dividends per sharevalue per share0.350.350.350.35
Diluted normalized EPSvalue per share0.750.600.771.12